Hematology and Oncology
Home Hematology and Oncology
Most Women Willing to Trade Off Benefits, Risks of Breast Screening
Women are willing to accept 1.72 additional unnecessary follow-ups and willing to pay £79.17
No Benefit for Aggressive Therapy in Metastatic Prostate Cancer
However, mortality higher with conservative therapy in locally advanced, non-metastatic prostate cancer
AAOS: Stem Cell Tx for Knee OA Costs About $5,000 Per Injection
High cost, rapidly expanding use despite low-level evidence; mean marketed clinical efficacy of 82.2%
Single PSA Screening Doesn’t Cut Prostate Cancer Mortality
But screening is associated with increased detection of low-risk prostate cancer
Limited Evidence for Clinical Validity, Utility of ctDNA
No evidence for circulating tumor DNA assays in early-stage cancer, residual disease detection
Excretion of Volatile Organic Compounds Up in Teen E-Smokers
Excretion of metabolites of acrylonitrile, acrolein, propylene oxide, acrylamide, crotonaldehyde up
Increase in Other Flavored Tobacco Use After Menthol Ban
Increase in percentage of those who attempted to quit at follow-up versus before ban implementation
Risk of Mental Health Visits Up in Childhood Cancer Survivors
Childhood cancer survivors diagnosed by age 4 have elevated risk of severe mental health events
Unmet Health Needs for Patients With Uveal Melanoma
Most express unmet needs at 1 week, 3 months after diagnosis; drop in unmet needs over time
Calcium ± Vit D Supplements Up Risk of Colon Adenomas, Polyps
Late effect findings of sessile serrated adenomas, polyps in those taking calcium with/without vitamin D
